Ascendis Pharma Endocrinology Division A/s

This study follows 500 children with growth hormone deficiency who are already taking lonapegsomatropin. Researchers will watch for long-term side effects like cancer or diabetes. The goal is to learn more about the drug's safety in everyday use, not to test a new treatment.

This study follows about 900 children with growth hormone deficiency who are already taking SKYTROFA. Researchers will track side effects and measure how close children get to normal adult height. The goal is to see how well the drug works in everyday medical practice.